Fate Therapeutics Inc.

12/09/2024 | Press release | Distributed by Public on 12/09/2024 15:04

Fate Therapeutics Presents New Phase 1 Clinical Data of FT819 Off the shelf, CAR T cell Product Candidate for Systemic Lupus Erythematosus